Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss. [electronic resource]
Producer: 20150708Description: 1151-61 p. digitalISSN:- 1433-2965
- Aged
- Aged, 80 and over
- Alendronate -- pharmacology
- Alkaline Phosphatase -- metabolism
- Bone Density -- drug effects
- Bone Density Conservation Agents -- pharmacology
- Cell Differentiation -- drug effects
- Cells, Cultured
- Diphosphonates -- pharmacology
- Female
- Humans
- Imidazoles -- pharmacology
- Mesenchymal Stem Cells -- drug effects
- Osteogenesis -- drug effects
- Osteopontin -- physiology
- Osteoporosis, Postmenopausal -- drug therapy
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.